Evidence map›Paper›PMID 26359493›Full record

ArticleThe Journal of biological chemistry2015

Saturation Mutagenesis of the Antithrombin Reactive Center Loop P14 Residue Supports a Three-step Mechanism of Heparin Allosteric Activation Involving Intermediate and Fully Activated States.

Ryan Roth, Richard Swanson, Gonzalo Izaguirre, Susan C Bock, Peter G W Gettins, Steven T Olson

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ryan RothCenter for Molecular Biology of Oral Diseases and Departments of Periodontics.
Richard SwansonCenter for Molecular Biology of Oral Diseases and Departments of Periodontics.
Gonzalo IzaguirreCenter for Molecular Biology of Oral Diseases and Departments of Periodontics.
Susan C BockDepartments of Medicine and Bioengineering, University of Utah, Salt Lake City, Utah 84132.
Peter G W GettinsBiochemistry and Molecular Genetics, University of Illinois at Chicago, Chicago, Illinois 60612.
Steven T OlsonCenter for Molecular Biology of Oral Diseases and Departments of Periodontics. Electronic address: stolson@uic.edu.
University of Illinois Chicago · USUniversity of Utah · US

Funding

Molecular Basis of Blood Coagulation RegulationR37HL039888 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI OLSON, STEVEN T. · 2010 to 2019
$3.9M
NHLBI NIH HHS R37 HL039888NHLBI NIH HHS R37 HL39888
6 · The paper itself

Abstract

Past studies have suggested that a key feature of the mechanism of heparin allosteric activation of the anticoagulant serpin, antithrombin, is the release of the reactive center loop P14 residue from a native state stabilizing interaction with the hydrophobic core. However, more recent studies have indicated that this structural change plays a secondary role in the activation mechanism. To clarify this role, we expressed and characterized 15 antithrombin P14 variants. The variants exhibited basal reactivities with factors Xa and IXa, heparin affinities and thermal stabilities that were dramatically altered from wild type, consistent with the P14 mutations perturbing native state stability and shifting an allosteric equilibrium between native and activated states. Rapid kinetic studies confirmed that limiting rate constants for heparin allosteric activation of the mutants were altered in conjunction with the observed shifts of the allosteric equilibrium. However, correlations of the P14 mutations' effects on parameters reflecting the allosteric activation state of the serpin were inconsistent with a two-state model of allosteric activation and suggested multiple activated states. Together, these findings support a minimal three-state model of allosteric activation in which the P14 mutations perturb equilibria involving distinct native, intermediate, and fully activated states wherein the P14 residue retains an interaction with the hydrophobic core in the intermediate state but is released from the core in the fully activated state, and the bulk of allosteric activation has occurred in the intermediate.

Indexed as

Allosteric RegulationAntithrombinsHeparinKineticsMutationPeptide HydrolasesProtein BindingAntithrombinsHeparinPeptide Hydrolasesallosteric regulationanticoagulantantithrombin (AT)coagulation factorheparinproteaseprotease inhibitorserine proteaseserpin

Identifiers

PMID26359493
PMCPMC4653662
OpenAlexW2178524435

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.